Diabetic Eye Disease and Diabetic Retinopathy

Diabetic eye disease is a complication of Diabetes Mellitus. Diabetic retinopathy is often detected as a complication, and it presents by affecting small blood vessels in the eye due to blockage or leakage. Over time, blood vessels can present as microaneurysms or hemorrhages or fluid (exudates). The number and severity of affected vessels determine the grade or retinopathy. There are 2 forms, nonproliferative (NPDR) and proliferative (PDR). 

optomap imaging has been shown to improve the management of diabetes in patients. optomap images capture a 200° view (about 82%) of the retina versus the 75° view provided by 7SF images. Studies have shown that this wider view can uncover evidence of disease that is outside the narrow view of 7SF images. It can even change how doctors judge the severity of the disease. In addition, the latest study identified that 50% of the lesions were in the area outside of ETDRS and that in 13% of patients, these lesions suggested a more severe grade of retinopathy.

Evidence of disease at the periphery of the retina can also be a sign of future problems. Patients with peripheral DR lesions were more than four times more likely to see their DR get worse as compared to patients without lesions.

Diabetic retinopathy can impact people of all ages and in cases of diabetic eye diseases and further complications, early detection is key. optomap can help doctors to better monitor and facilitate decision making regarding treatment.

optomap Equivalent to ETDRS

Results from a large multi-center collaborative study confirm the equivalence of optomap to ETDRS Gold Standard for grading diabetic retinopathy.

10/26/2018

Peripheral Lesions Identified on Ultrawide Field Imaging Predict Increased Risk of Diabetic Retinopathy Progression over 4 Years

optomap imaging has demonstrated that diabetic lesions occur in the retinal periphery in up to 50% of eyes and these lesions might result in a more severe grade of retinopathy in 10% of eyes. Eyes with predominantly peripheral lesions (defined as outside of ETDRS 7 standard field) had a 4.7 fold increased risk of progression to proliferative diabetic retinopathy (PDR). Eyes with predominantly peripheral lesions had a 3.2 fold risk of 2 step progression in DR.

8/16/2020

optomap Helpful in Telemedicine Programs

Several studies published in Diabetes Care have found that optomap detected 17% more diabetic retinopathy and was more efficient than traditional non-mydriatic fundus imaging.

8/16/2018

optomap fa - Key Indicator in Progression to PDR

Research using optomap fa reveals that 50% of eyes with baseline predominantly peripheral lesions (PPL) are at high risk for diabetic retinopathy (DR) progression.

Luke Nicholson, FRCOphth; Jayashree Ramu, MBBS; Errol W. Chan, FRCOphth; James W. Bainbridge, PhD.

8/1/2019

optomap Multimodal Diabetic Eye Disease Cases

Optos offers multimodal imaging with all ultra-widefield devices. Having both ultra-widefield and four images captured in less than one second has been shown to enhance pathology detection and disease management as well as improve practice and clinic flow. Ultra-widefield multimodal imaging is important across all access points of patient care - screening, detection, diagnosis, and treatment. 

Other Diagnostic Tools

Booklet Atlas Color

How can we help?

I want to receive email updates about Optos products and services